Vantrexa · SCLC · Japan · Radiation oncologist · captured by Mei Tanaka on 02 Sept 2026 · reviewed by Dr. Priya Raman on 07 Sept 2026
Verbatim as captured; never edited
Radiation oncologist at Osaka University Hospital raised infusion-reaction management during a scientific exchange. They noted that colleagues in their network share the view.
Human-approved by Dr. Priya Raman on 07 Sept 2026
Infusion-reaction management: practice variation observed reported by radiation oncologist (JP).
helixor-private-llm-2026.08 · generated 02 Sept 2026, 10:00 UTC
AI summary
Infusion-reaction management raised by radiation oncologist; relevant for Medical Communications.
Source spans used by the model
Radiation oncologist at Osaka University Hospital raised infusion-reaction management during a scientific exchange. They noted that colleagues in their network share the view.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Competitor activity | Competitor activity |
| Function | Medical Communications | Medical Communications |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 5 | 15% | 15.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 4 | 10% | 8.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 1 | 5% | 1.0 |
| Total | Medium 61 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
02 Sept 2026 · Dr. Ximena Rossi, Osaka University Hospital · MSL Mei Tanaka
Insight
Reviewed 07 Sept 2026 by Dr. Priya Raman
Action
Initiative
Decision
Outcome
Closure